MDW - Medication Therapy Management (MTM)

The District of Columbia’s Health Care Finance Agency is forecasting a future procurement for Medication Therapy Management services under the MDW program, with a posted date of July 23, 2026. This initiative aims to enhance patient care by providing comprehensive medication reviews and therapeutic interventions to optimize drug use, reduce adverse events, and improve health outcomes among eligible populations. Although the solicitation number, NAICS code, and set-aside details are not yet specified, the contract will likely target qualified healthcare providers or pharmacies capable of delivering structured MTM services within the district. The place of performance and agency office location are not defined, but services are expected to be delivered across the District of Columbia, aligning with local health priorities and Medicare or Medicaid guidelines for medication management. There is no point of contact listed at this forecast stage, and interested parties should monitor the official procurement portal for updates as the opportunity progresses toward formal solicitation.